Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; macrogol 6000; titanium dioxide; propylene glycol; maize starch; colloidal anhydrous silica; sodium starch glycollate; magnesium stearate; hypromellose; purified talc - treatment of type 2 diabetes mellitus in adults, particularly in over weight patients, when dietary management and exercise alone, does not result in adequate glycaemic control. metformin may be used as initial treatment, or in sulphonylurea failures, either alone or in combination with a sulphonylurea and other oral agents or as adjuvant therapy in insulin dependent diabetes.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

rex medical ltd - finasteride 5mg - film coated tablet - 5 mg - active: finasteride 5mg excipient: colloidal silicon dioxide docusate sodium benzoate lactose monohydrate magnesium stearate maize starch opadry blue 04f50702 sodium starch glycolate - finasteride 5mg film coated tablets are indicated for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to; · reduce the risk of acute urinary retention · reduce the risk of surgery including transuretheral resection of the prostate (turp) and prostatectomy. finasteride 5mg film coated tablets cause regression of the enlarged prostate, improved urinary flow and improves the symptoms associated with bph. patients with enlarged prostate are the appropriate candidates for therapy with finasteride 5mg film coated tablets.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 225 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; purified water; sunset yellow fcf; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 225 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; purified water; sunset yellow fcf; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 200 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 200 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 150 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 150 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.